Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
Clinical trial NCT07195149 · RECRUITING
Trial details
- NCT number
- NCT07195149
- Sponsor
- Dolnośląskie Centrum Chorób Serca im.prof. Zbigniewa Religi MEDINET Sp. z o.o.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-25
- Primary completion
- 2030-04-30
- Enrollment
- 1703
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.